UK markets open in 15 minutes

UnitedHealth Group Incorporated (UNH.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
460.70-1.40 (-0.30%)
As of 08:01AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 424.70B
Enterprise value 462.95B
Trailing P/E 30.18
Forward P/E 17.79
PEG ratio (5-yr expected) 1.40
Price/sales (ttm)1.22
Price/book (mrq)4.92
Enterprise value/revenue 1.22
Enterprise value/EBITDA 15.90

Trading information

Stock price history

Beta (5Y monthly) 0.56
52-week change 32.40%
S&P500 52-week change 321.08%
52-week high 3518.00
52-week low 3399.00
50-day moving average 3451.11
200-day moving average 3471.60

Share statistics

Avg vol (3-month) 3212
Avg vol (10-day) 3249
Shares outstanding 5920.08M
Implied shares outstanding 6922.92M
Float 8919.37M
% held by insiders 10.22%
% held by institutions 190.25%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 46.92
Forward annual dividend yield 41.50%
Trailing annual dividend rate 37.52
Trailing annual dividend yield 31.63%
5-year average dividend yield 41.36
Payout ratio 445.91%
Dividend date 3N/A
Ex-dividend date 408 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 4.05%
Operating margin (ttm)7.95%

Management effectiveness

Return on assets (ttm)7.09%
Return on equity (ttm)17.22%

Income statement

Revenue (ttm)379.49B
Revenue per share (ttm)411.26
Quarterly revenue growth (yoy)8.60%
Gross profit (ttm)N/A
EBITDA 35B
Net income avi to common (ttm)15.36B
Diluted EPS (ttm)15.30
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)32.71B
Total cash per share (mrq)35.48
Total debt (mrq)73.64B
Total debt/equity (mrq)75.98%
Current ratio (mrq)0.85
Book value per share (mrq)100.18

Cash flow statement

Operating cash flow (ttm)13.88B
Levered free cash flow (ttm)-4.55B